Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.
Ann Rheum Dis. 2018 Dec;77(12):1710-1719. doi: 10.1136/annrheumdis-2018-213150. Epub 2018 Sep 29.
Ann Rheum Dis. 2018.
PMID: 30269054
Free PMC article.
Clinical Trial.
Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study.
Brunner HI, Quartier P, Alexeeva E, Constantin T, Koné-Paut I, Marzan K, Schneider R, Wulffraat NM, Chasnyk V, Tirosh I, Kallinich T, Kuemmerle-Deschner J, Wouters C, Lauwerys B, Nikishina I, Trachana M, Vougiouka O, Martini A, Lovell DJ, Levy J, Vritzali E, Ruperto N; Paediatric Rheumatology International Trials Organisation, the Pediatric Rheumatology Collaborative Study Group.
Brunner HI, et al. Among authors: vritzali e.
Arthritis Rheumatol. 2020 Dec;72(12):2147-2158. doi: 10.1002/art.41436. Epub 2020 Oct 31.
Arthritis Rheumatol. 2020.
PMID: 32648697
Clinical Trial.
Item in Clipboard
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry.
Walker UA, Tilson HH, Hawkins PN, Poll TV, Noviello S, Levy J, Vritzali E, Hoffman HM, Kuemmerle-Deschner JB; CACZ885D2401 Study Investigators.
Walker UA, et al. Among authors: vritzali e.
RMD Open. 2021 May;7(2):e001663. doi: 10.1136/rmdopen-2021-001663.
RMD Open. 2021.
PMID: 34001647
Free PMC article.
Item in Clipboard
Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study.
Jaeger VK, Hoffman HM, van der Poll T, Tilson H, Seibert J, Speziale A, Junge G, Franke K, Vritzali E, Hawkins PN, Kuemmerle-Deschner J, Walker UA.
Jaeger VK, et al. Among authors: vritzali e.
Rheumatology (Oxford). 2017 Sep 1;56(9):1484-1491. doi: 10.1093/rheumatology/kex185.
Rheumatology (Oxford). 2017.
PMID: 28482054
Free article.
Item in Clipboard
Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study.
Vassilopoulos D, Delicha EM, Settas L, Andrianakos A, Aslanidis S, Boura P, Katsounaros M, Athanassiou P, Tempos K, Skarantavos G, Antoniadis C, Papazoglou S, Sakkas L, Galanopoulou V, Skopouli F, Boki K, Daoussis D, Vritzali E, Sfikakis PP.
Vassilopoulos D, et al. Among authors: vritzali e.
Clin Exp Rheumatol. 2016 Sep-Oct;34(5):893-900. Epub 2016 Jul 5.
Clin Exp Rheumatol. 2016.
PMID: 27383049
Free article.
Item in Clipboard
Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece.
Athanasakis K, Tarantilis F, Tsalapati K, Konstantopoulou T, Vritzali E, Kyriopoulos J.
Athanasakis K, et al. Among authors: vritzali e.
Rheumatol Int. 2015 Sep;35(9):1489-95. doi: 10.1007/s00296-015-3253-x. Epub 2015 Mar 21.
Rheumatol Int. 2015.
PMID: 25794569
Item in Clipboard
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials.
Lebwohl M, Warren RB, Sofen H, Imafuku S, Paul C, Szepietowski JC, Spelman L, Passeron T, Vritzali E, Napoli A, Kisa RM, Buck A, Banerjee S, Thaçi D, Blauvelt A.
Lebwohl M, et al. Among authors: vritzali e.
Br J Dermatol. 2024 Apr 17;190(5):668-679. doi: 10.1093/bjd/ljae014.
Br J Dermatol. 2024.
PMID: 38226713
Clinical Trial.
Item in Clipboard
Cite
Cite